Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Krohn R, Raffetseder U, Bot I, Zernecke A, Shagdarsuren E, Liehn EA, van Santbrink PJ, Nelson PJ, Biessen EA, Mertens PR, Weber C. Krohn R, et al. Among authors: van santbrink pj. Circulation. 2007 Oct 16;116(16):1812-20. doi: 10.1161/CIRCULATIONAHA.107.708016. Epub 2007 Sep 24. Circulation. 2007. PMID: 17893273
Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.
de Nooijer R, Bot I, von der Thüsen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO, Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van der Wall EE, van Berkel TJ, Shi GP, Biessen EA. de Nooijer R, et al. Among authors: van der wall ee, van berkel tj, van santbrink pj, van heiningen sh. Arterioscler Thromb Vasc Biol. 2009 Feb;29(2):188-94. doi: 10.1161/ATVBAHA.108.181578. Epub 2008 Dec 18. Arterioscler Thromb Vasc Biol. 2009. PMID: 19095996
Impaired effector memory T-cell regulation facilitates graft versus host disease in CCR7-deficient bone marrow transplant chimeras.
de Jager SC, Canté-Barrett K, Bot I, Husberg C, van Puijvelde GH, van Santbrink PJ, Yndestad A, van den Oever JM, Kuiper J, van Berkel TJ, Lipp M, Zwaginga JJ, Fibbe WE, Aukrust P, Biessen EA. de Jager SC, et al. Among authors: van berkel tj, van den oever jm, van puijvelde gh, van santbrink pj. Transplantation. 2009 Sep 15;88(5):631-9. doi: 10.1097/TP.0b013e3181b241df. Transplantation. 2009. PMID: 19741459
Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
Bot I, de Vries H, Korporaal SJ, Foks AC, Bot M, van Veldhoven J, Ter Borg MN, van Santbrink PJ, van Berkel TJ, Kuiper J, Ijzerman AP. Bot I, et al. Among authors: van veldhoven j, van berkel tj, van santbrink pj. Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2197-205. doi: 10.1161/ATVBAHA.112.252924. Epub 2012 Jun 28. Arterioscler Thromb Vasc Biol. 2012. PMID: 22743060
Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
Calpe-Berdiel L, Zhao Y, de Graauw M, Ye D, van Santbrink PJ, Mommaas AM, Foks A, Bot M, Meurs I, Kuiper J, Mack JT, Van Eck M, Tew KD, van Berkel TJ. Calpe-Berdiel L, et al. Among authors: van berkel tj, van santbrink pj, van eck m. Atherosclerosis. 2012 Aug;223(2):332-41. doi: 10.1016/j.atherosclerosis.2012.05.039. Epub 2012 Jun 12. Atherosclerosis. 2012. PMID: 22748276 Free article.
Interference of the CD30-CD30L pathway reduces atherosclerosis development.
Foks AC, Bot I, Frodermann V, de Jager SC, Ter Borg M, van Santbrink PJ, Yagita H, Kuiper J, van Puijvelde GH. Foks AC, et al. Among authors: van santbrink pj, van puijvelde gh. Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2862-8. doi: 10.1161/ATVBAHA.112.300509. Epub 2012 Oct 18. Arterioscler Thromb Vasc Biol. 2012. PMID: 23087358
37 results